EUVIMEDEUVIMED entdecken
Crossref

Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein

Sebastian Schellhorn, Dominik Brücher, Natascha A Wolff, Katrin Schröer, Erwan Sallard, Kemal Mese, Wenli Zhang, Eric Ehrke-Schulz iD, Frank Thévenod, Andreas Plückthun, Anja Ehrhardt iD

Human Gene Therapy · 2023

DOI: 10.1089/hum.2022.215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy, 2023. Verfasst von Sebastian Schellhorn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, Wi…. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Neoplasms. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirusesOncolytic VirotherapyNeoplasmsAnimalsCricetinaeAdenoviridaeLipocalin-2Ankyrin RepeatCHO CellsDesigned Ankyrin Repeat ProteinsCricetulusLigandsCell Line, TumorLuciferasesVirus Replication

Stichwörter der Autor:innen

DARPinLipocalin-2adenoviral vectoradenoviruscancervirotherapy

Substanzen

Lipocalin-2Designed Ankyrin Repeat ProteinsLigandsLuciferases

Autor:innen und Institutionen

  • Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
  • Department of Biochemistry, University of Zurich, Zurich, Switzerland.
  • Institute of Physiology, Pathophysiology, and Toxicology, Center for Biomedical Training and Research (ZBAF), Witten/Herdecke University, Witten, Germany.

ORCID-Profile: Eric Ehrke-Schulz, Anja Ehrhardt

Zitieren

APA

Schellhorn, S., Brücher, D., Wolff, N. A., Schröer, K., Sallard, E., Mese, K., Zhang, W., Ehrke-Schulz, E., Thévenod, F., Plückthun, A., & Ehrhardt, A. (2023). Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein. Human Gene Therapy. https://doi.org/10.1089/hum.2022.215

Vancouver

Schellhorn S, Brücher D, Wolff NA, Schröer K, Sallard E, Mese K, et al. Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein. Human Gene Therapy. 2023. doi:10.1089/hum.2022.215

BibTeX
@article{Schellhorn2023,
  author = {Schellhorn, Sebastian and Brücher, Dominik and Wolff, Natascha A and Schröer, Katrin and Sallard, Erwan and Mese, Kemal and Zhang, Wenli and Ehrke-Schulz, Eric and Thévenod, Frank and Plückthun, Andreas and Ehrhardt, Anja},
  title = {Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein},
  journal = {Human Gene Therapy},
  year = {2023},
  doi = {10.1089/hum.2022.215}
}
Kostenlos starten →